Topics

CaseBased Panel Discussion - Unresectable NSCLC, Should Molecular Tests be Considered, and Would Outcome Effect Treatment Decisions?

18:45 EST 14 Jan 2020 | GRACE
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC .   

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Dr. Matthew Gubens is a thoracic oncologist who treats patients with lung cancer, mesothelioma and other thoracic malignancies, including thymoma and thymic carcinoma, which are rare tumors of the mediastinum. He is an Assistant Clinical Professor of Medicine at UCSF.

Recently the doctors sat down to discuss a series of case-based scenarios.   In this video, the doctors discuss the option of molecular testing for stage 3 NSCLC, and whether or not the outcome effects treatment decisions.

 

 

Video Language: 

Original Article: CaseBased Panel Discussion - Unresectable NSCLC, Should Molecular Tests be Considered, and Would Outcome Effect Treatment Decisions?

NEXT ARTICLE

More From BioPortfolio on "CaseBased Panel Discussion - Unresectable NSCLC, Should Molecular Tests be Considered, and Would Outcome Effect Treatment Decisions?"

Quick Search

Relevant Topics

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...